KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Change in Receivables (2016 - 2025)

Exact Sciences (EXAS) has disclosed Change in Receivables for 11 consecutive years, with -$7.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Change in Receivables rose 51.54% to -$7.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $48.9 million, a 5.69% increase, with the full-year FY2025 number at $48.9 million, up 5.69% from a year prior.
  • Change in Receivables was -$7.3 million for Q4 2025 at Exact Sciences, up from -$46.9 million in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $73.0 million in Q2 2025 to a low of -$46.9 million in Q3 2025.
  • A 5-year average of $2.6 million and a median of $1.6 million in 2022 define the central range for Change in Receivables.
  • Peak YoY movement for Change in Receivables: skyrocketed 643.77% in 2023, then crashed 9304.91% in 2025.
  • Exact Sciences' Change in Receivables stood at -$39.2 million in 2021, then rose by 15.48% to -$33.1 million in 2022, then skyrocketed by 109.39% to $3.1 million in 2023, then tumbled by 587.17% to -$15.2 million in 2024, then surged by 51.54% to -$7.3 million in 2025.
  • Per Business Quant, the three most recent readings for EXAS's Change in Receivables are -$7.3 million (Q4 2025), -$46.9 million (Q3 2025), and $73.0 million (Q2 2025).